SORILUX (Stiefel Laboratories Inc)
Welcome to the PulseAid listing for the SORILUX drug offered from Stiefel Laboratories Inc. This Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Stiefel Laboratories Inc |
| NON-PROPRIETARY NAME: | calcipotriene |
| SUBSTANCE NAME: | CALCIPOTRIENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | AEROSOL, FOAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-10-26 |
| END MARKETING DATE: | 2018-10-31 |
SORILUX HUMAN PRESCRIPTION DRUG Details:
| Item Description | SORILUX from Stiefel Laboratories Inc |
| LABELER NAME: | Stiefel Laboratories Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(ug/g) |
| START MARKETING DATE: | 2010-10-26 |
| END MARKETING DATE: | 2018-10-31 |
| PRODUCT ID: | 0145-2130_8469d93a-5a7a-4c39-8127-e822642f3f58 |
| PRODUCT NDC: | 0145-2130 |
| APPLICATION NUMBER: | NDA022563 |
Other CALCIPOTRIENE Pharmaceutical Manufacturers / Labelers:
